SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$275.43

Market cap

$105.65B

P/E Ratio

28.28

Dividend/share

$3.52

EPS

$9.74

Enterprise value

$117.2B

?
Relative Growth: Rel. Growth: 90
Relative Strength: Rel. Strength: 24
Relative Valuation: Rel. Valuation: 46
Relative Profitability: Rel. Profitability: 86

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and ...

Highlights
SYK's P/E is 32% below its 5-year quarterly average of 41.6 and 29% below its last 4 quarters average of 39.8
SYK's net income is up by 28% year-on-year and by 12% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.stryker.com
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK

SYK stock price

How has the Stryker stock price performed over time
Intraday
0.9%
1 week
1.13%
1 month
-11.77%
1 year
-24.83%
YTD
-21.63%
QTD
0.01%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$25.84B
Gross profit
$16.79B
Operating income
$5.53B
Net income
$3.73B
Gross margin
65%
Net margin
14.4%
The operating income has surged by 53% year-on-year and by 11% since the previous quarter
Stryker's operating margin has increased by 41% YoY and by 9% QoQ
SYK's net income is up by 28% year-on-year and by 12% since the previous quarter
SYK's net margin is up by 17% YoY and by 9% from the previous quarter

Price vs fundamentals

How does SYK's price correlate with its fundamentals

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
SYK P/E details
P/E
28.28
P/B
4.4
P/S
4.09
EV/EBIT
19.39
EV/EBITDA
17.94
EV/Sales
4.54
SYK's P/E is 32% below its 5-year quarterly average of 41.6 and 29% below its last 4 quarters average of 39.8
Stryker's EPS has increased by 27% YoY and by 11% from the previous quarter
SYK's P/B is 29% below its 5-year quarterly average of 6.2 and 23% below its last 4 quarters average of 5.7
SYK's equity is up by 13% year-on-year and by 4.4% since the previous quarter
The stock's price to sales (P/S) is 27% less than its 5-year quarterly average of 5.6 and 21% less than its last 4 quarters average of 5.2
The company's revenue rose by 8% YoY and by 2.2% QoQ

Efficiency

How efficient is Stryker business performance
Stryker's ROIC has increased by 45% YoY and by 11% from the previous quarter
Stryker's ROS has increased by 38% YoY and by 7% from the previous quarter
The ROA has grown by 22% YoY and by 11% from the previous quarter
The ROE rose by 16% YoY and by 9% QoQ

Dividends

What is SYK's dividend history
Dividend details
DPS
$3.52
Dividend yield
1.28%
Payout ratio
36.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Stryker financials performed over time
The total assets is 100% greater than the total liabilities
SYK's quick ratio is up by 23% YoY and by 4.9% from the previous quarter
The current ratio has grown by 21% year-on-year and by 2.4% since the previous quarter
SYK's debt is 38% less than its equity
The debt to equity has contracted by 21% YoY and by 3.1% from the previous quarter
SYK's equity is up by 13% year-on-year and by 4.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.